Related Experiment Video
Updated: Jun 21, 2025

12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.4K
Immunotherapies for Childhood Cancer
Jeong A Park1, Nai-Kong V Cheung2
1Department of Pediatrics, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.
Cold Spring Harbor Perspectives in Medicine
|July 15, 2024
Summary
Pediatric cancer survival is improving, but some children still face relapse. Immunotherapies, like GD2 antibodies for neuroblastoma and CD19-targeted therapies for acute lymphoblastic leukemia, offer new hope.
Area of Science:
- Pediatric Oncology
- Cancer Immunotherapy
Background:
- Pediatric cancer survival rates have significantly improved over 50 years.
- A subset of pediatric cancer patients (10%-15%) experience disease relapse or refractory conditions.
- Conventional chemotherapy intensification shows limited efficacy and high toxicity, necessitating novel therapeutic approaches.
Purpose of the Study:
- To review the clinical development of immunotherapies for pediatric cancers.
- To focus on advancements in neuroblastoma and acute lymphoblastic leukemia.
- To discuss future directions in pediatric cancer immunotherapy.
Main Methods:
- Review of clinical trials and research on immunotherapy in pediatric oncology.
- Focus on monoclonal antibodies targeting GD2 and CD19-targeted bispecific antibodies (BsAbs) and chimeric antigen receptor (CAR) T cells.
- Analysis of treatment outcomes and survival data for neuroblastoma and acute lymphoblastic leukemia.
Main Results:
- Monoclonal antibodies targeting GD2 show durable responses in neuroblastoma.
- CD19-targeted BsAbs and CAR T cells have improved outcomes for refractory acute lymphoblastic leukemia.
- Immunotherapy represents a paradigm shift in treating specific pediatric malignancies.
Conclusions:
- Immunotherapy is a promising and evolving field for pediatric cancer treatment.
- Targeted immunotherapies have transformed the prognosis for neuroblastoma and acute lymphoblastic leukemia.
- Continued research is vital to expand the application and efficacy of immunotherapies in pediatric oncology.
Related Concept Videos
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Vaccines
350
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
350
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Immunodeficiency Diseases
933
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
933

